IP Library Granted Patent US 9,956,336
Granted Patent B2
US 9,956,336 · App. 14/077,005 · Granted May 1, 2018

Methods of using a fluid management system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,956,336
App. No.
14/077,005
Granted
May 1, 2018
Kind
B2
Abstract

An artificial liver system for treating liver failure includes a reservoir to provide albumin-containing dialysis fluid to the patient's peritoneum, an implantable device including a pump to pump the fluid from the peritoneum to the bladder via respective catheters, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve data reflective of the patient's health; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The monitoring and control software allows a treating physician to remotely adjust the volume, time, and frequency with which fluid is pumped from the peritoneal cavity to the bladder based on the data reflective of the patient's health.

Claims (31)

1. A method of using a fluid management system with a patient having a peritoneum and a bladder, the method comprising:

introducing a peritoneal dialysis fluid from a reservoir to the patient's peritoneum;

pumping, using an implantable device, the peritoneal dialysis fluid in the peritoneum to the patient's bladder via a peritoneal catheter and a bladder catheter;

transferring data from the implantable device to a charging and communication system external to the patient;

providing the data from the charging and communication system to monitoring and control software running on a computer separate from the charging and communication system; and

communicating operational parameters from the monitoring and control software to the implantable device via the charging and communication system to control the pumping.

2. The method of claim 1 , wherein the implantable device comprises a housing containing a positive displacement gear pump coupled an electric motor and a first controller coupled to a battery, a first transceiver, and a first inductive charging circuit.

3. The method of claim 2 , wherein the charging and communication system comprises a second controller coupled to a second transceiver and a second inductive charging circuit and wherein the charging and communication system is configured to wirelessly transfer the data with the implantable device via the first and second transceivers,

the method further comprising wirelessly transferring energy from the second inductive circuit to the first inductive circuit to charge the battery.

4. The method of claim 1 , wherein the reservoir is configured for external use.

5. The method of claim 4 , wherein introducing the peritoneal dialysis fluid further comprises introducing the peritoneal dialysis fluid from the reservoir to the patient's peritoneum using an external pump.

6. The method of claim 4 , further comprising providing a belt configured to secure the reservoir to the patient's body.

7. The method of claim 6 , wherein the reservoir comprises at least one pouch arranged along the length of the belt.

8. The method of claim 1 , wherein the reservoir is configured for internal implantation and comprises a port configured to receive fresh peritoneal dialysis fluid.

9. The method of claim 1 , wherein the data comprises measurements of at least one of: respiratory rate, fluid temperature, fluid viscosity, fluid pressure in the peritoneum, or fluid pressure in the bladder measured by at least one sensor coupled to the implantable device.

10. The method of claim 1 , wherein transferring the data comprises wirelessly downloading the data stored on the implantable device to a memory disposed within the charging and communication system.

11. The method of claim 10 , wherein providing the data comprises periodically communicating via the monitoring and control software with the charging and communication system, using either a wired or wireless connection, to retrieve the data stored in the memory.

12. The method of claim 1 , further comprising:

detecting a change in the patient's health based on an increase in at least one of a measured respiratory rate, fluid temperature, or fluid viscosity above a predefined threshold; and

displaying information about the detected change in the patient's health on a display of the computer.

13. The method of claim 12 , further comprising:

modifying the operational parameters of the implantable device based on the detected change in the patient's health; and

communicating the modified operational parameters from the monitoring and control software to the implantable device via the charging and communication system.

14. The method of claim 13 , wherein the modified operational parameters include at least one of: a volume of the peritoneal dialysis fluid, a time period for which the peritoneal dialysis fluid is permitted to remain within the patient's peritoneum, or a frequency with which peritoneal dialysis fluid is removed from the patient's peritoneum to the bladder.

15. The method of claim 12 , wherein the detected change in the patient's health is an infection or a change in liver function.

16. The method of claim 1 , further comprising exposing the peritoneal dialysis fluid to light from a UV lamp for a sufficient amount of time to inhibit the growth of colonies of one or more pathogens.

17. The method of claim 1 , wherein the method is for treating liver failure.

18. The method of claim 1 , wherein the pumping comprises moving the fluid during predetermined time periods and in predetermined volumes responsive to the operational parameters communicated by the monitoring and control software.

19. The method of claim 1 , further comprising operating the implantable device in a tick mode to reduce potential clogging, substantially without moving fluid.

20. The method of claim 1 , further comprising rapidly alternating a motor of the implantable device between forward and reverse directions to unblock a gear pump of the implantable device.

21. The method of claim 1 , wherein the peritoneal dialysis fluid comprises albumin.

Assignments (5)
SECURITY INTEREST Recorded Sep 25, 2024
From: SEQUANA MEDICAL NV
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 069049/0129 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2020
From: BOOTSTRAP EUROPE S.C.SP.
To: SEQUANA MEDICAL NV
Reel/Frame 053375/0176 →
CHANGE OF NAME Recorded Jun 9, 2019
From: SEQUANA MEDICAL AG
To: SEQUANA MEDICAL NV
Reel/Frame 049414/0245 →
SECURITY INTEREST Recorded Sep 28, 2016
From: SEQUANA MEDICAL AG
To: BOOTSTRAP EUROPE S.C.SP.
Reel/Frame 039884/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: DEGEN, THOMAS WERNER; THOMMEN, DANIEL THOMAS; JOHNSON, NOEL L.
To: SEQUANA MEDICAL AG
Reel/Frame 032650/0907 →